Brinker Capital Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Brinker Capital Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-38,449	Closed	-$4.38M	–	1685
2022 Q4	$4.38M	Buy	38,449 +901	+2%	+$74.8K	0.09%	229
2022 Q3	$2.32M	Buy	37,548 +721	+2%	+$50.4K	0.05%	396
2022 Q2	$2.94M	Sell	36,827 -269	-0.7%	-$25.5K	0.06%	330
2022 Q1	$3.9M	Buy	37,096 +4,357	+13%	+$425K	0.06%	302
2021 Q4	$3.53M	Sell	32,739 -3,058	-9%	-$334K	0.05%	367
2021 Q3	$3.35M	Hold	35,797	–	–	0.05%	376
2021 Q2	$3.35M	Buy	35,797 +29,692	+486%	+$2.73M	0.04%	430
2021 Q1	$562K	Sell	6,105 -33,113	-84%	-$2.79M	0.01%	870
2020 Q4	$2.87M	Buy	39,218 +34,437	+720%	+$2.56M	0.04%	464
2020 Q3	$371K	Buy	+4,781	New	+$329K	0.01%	970
2020 Q1	–	Sell	-483	Closed	-$17K	–	826
2019 Q4	$17K	Hold	483	–	–	﹤0.01%	524
2019 Q3	$13K	Hold	483	–	–	﹤0.01%	550
2019 Q2	$12K	Buy	+483	New	+$12.3K	﹤0.01%	764
2017 Q4	–	Sell	-227	Closed	-$3K	–	632
2017 Q3	$3K	Hold	227	–	–	﹤0.01%	544
2017 Q2	$3K	Hold	227	–	–	﹤0.01%	456
2017 Q1	$3K	Hold	227	–	–	﹤0.01%	440
2016 Q4	$4K	Buy	227 +224	+7,467%	+$4.06K	﹤0.01%	450
2016 Q3	$0	Buy	+3	New	+$59	﹤0.01%	656
2016 Q1	–	Sell	-5	Closed	–	–	744
2015 Q4	$0	Buy	+5	New	+$97	﹤0.01%	778

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brinker Capital Investments's HZNP Position: Q1 2023 in Review

Brinker Capital Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 38,449 shares — an estimated $4.38M sold.

Brinker Capital Investments first reported a position in HZNP in Q4 2015 and held it in 19 quarters. The position peaked at $4.38M in Q4 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Brinker Capital Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Brinker Capital Investments sold 38,449 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $4.38M.
Brinker Capital Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 19 quarters.
Brinker Capital Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.38M in Q4 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Brinker Capital Investments's 13F filing for Q1 2023, filed 31 Jul 2025.